-+ 0.00%
-+ 0.00%
-+ 0.00%

Hi-Vision Medical (02407) signed a five-year exclusive agency agreement with HEIDELBERG for the T3 corneal confocal microscope

Zhitongcaijing·08/17/2026 12:25:12
Listen to the news

Zhitong Finance App News, Gaoshi Healthcare (02407) announced that Gaoshi Innovation Technology Co., Ltd. (Gaoshi Innovation), a subsidiary of the company, recently signed a five-year exclusive agency agreement with German HEIDELBERG ENGINEERING GmbH (HEIDELBERG) for the T3 corneal confocal microscope independently developed and produced by Gaoshi Innovation. According to this agreement, HEIDELBERG will sell related products as an exclusive agent on a global scale other than China, and will be responsible for marketing and corresponding technical services.

The T3 corneal confocal microscope independently developed and produced by Gaoshi Innovation can observe the cornea and conjunctiva in vivo and assist in diagnosing various corneal diseases: infectious diseases, non-infectious diseases, including corneal degeneration, malnutrition, immune lesions, keratoconus, and corneal lesions related to surgery, trauma, dry eye, and systemic diseases, etc., providing a basis for disease diagnosis and condition evaluation.

HEIDELBERG is a leading global provider of ophthalmic diagnostic solutions, headquartered in Germany. Since the company was founded in 1998, the company has been an exclusive distributor of HEIDELBERG's ophthalmic imaging systems in China, and the two sides are important business partners for each other.